[VYNE] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
07-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -53.91%
YoY- -57.21%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 0 0 -10,640 0 10,143 497 2,775 -
PBT -16,477 -18,873 -17,594 -12,847 -8,347 -12,657 -9,277 46.81%
Tax 0 0 -11 0 0 0 -2 -
NP -16,477 -18,873 -17,594 -12,847 -8,347 -12,657 -9,277 46.81%
Tax Rate - - - - - - - -
Total Cost 16,477 18,873 6,954 12,847 18,490 13,154 12,052 23.25%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 0.00 0.00 165.36 0.00 -82.29 -2,546.68 -334.31 -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -49.65 -58.35 -54.68 -40.26 -26.28 -51.83 -32.43 32.93%
EPS Diluted -49.65 -58.35 -54.68 -40.26 -26.28 -51.83 -32.43 32.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.